Clinical Trial Update: The ASCEND Study: A Study to Investigate the Safety and Clinical Effect of Nexagon to Treat Slow Healing Diabetic Foot Ulcers [Phase 1, Phase 2]

View source ↗

Summary

The ASCEND trial evaluating Nexagon for slow-healing diabetic foot ulcers (Phase 1/Phase 2) has been terminated, with no results reported in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• NEXAGON

Snippet

Sponsor: OcuNexus Therapeutics, Inc. | Conditions: Diabetic Foot Ulcer | Phase 1, Phase 2 | Status: TERMINATED